Literature DB >> 21347098

Parametric survival models for predicting the benefit of adjuvant chemoradiotherapy in gallbladder cancer.

Samuel J Wang1, Jayashree Kalpathy-Cramer, Jong Sung Kim, C David Fuller, Charles R Thomas.   

Abstract

The Cox proportional hazards model is the most commonly used survival model in oncology; however, this semi-parametric model may not be the most appropriate survival model when the proportionality assumption does not hold. In this study, we consider the use of several types of accelerated failure time parametric survival techniques for modeling the benefit of adjuvant chemoradiotherapy for gallbladder cancer. In comparing the Weibull, exponential, log-logistic, and log-normal models, we found that the log-normal had the most favorable Akaike Information Criterion, and additional analyses of this model indicated that our gallbladder cancer dataset exhibited a good fit with the log-normal cumulative hazard function. This log-normal survival model can be used to help predict which patients will benefit from adjuvant chemoradiotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 21347098      PMCID: PMC3041378     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  6 in total

1.  Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis.

Authors:  Clifton D Fuller; Samuel J Wang; Mehee Choi; Brian G Czito; John Cornell; Tania M Welzel; Katherine A McGlynn; Join Y Luh; Charles R Thomas
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

2.  Parametric survival analysis of adjuvant therapy for stage II breast cancer.

Authors:  J W Gamel; R L Vogel; P Valagussa; G Bonadonna
Journal:  Cancer       Date:  1994-11-01       Impact factor: 6.860

3.  A stable, multivariate extension of the log-normal survival model.

Authors:  J W Gamel; I W McLean
Journal:  Comput Biomed Res       Date:  1994-04

4.  Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.

Authors:  Judith-Anne W Chapman; H Lavina A Lickley; Maureen E Trudeau; Wedad M Hanna; Harriette J Kahn; David Murray; Carol A Sawka; Betty G Mobbs; David R McCready; Kathleen I Pritchard
Journal:  Breast J       Date:  2006 Jan-Feb       Impact factor: 2.431

5.  Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the Cancer Registry of Norway.

Authors:  L E Rutqvist; A Wallgren; B Nilsson
Journal:  Cancer       Date:  1984-04-15       Impact factor: 6.860

6.  Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment.

Authors:  Patricia Tai; Judith-Anne W Chapman; Edward Yu; Dennie Jones; Changhong Yu; Fei Yuan; Lee Sang-Joon
Journal:  BMC Cancer       Date:  2007-02-20       Impact factor: 4.430

  6 in total
  8 in total

1.  Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

Authors:  Samuel J Wang; Andrew Lemieux; Jayashree Kalpathy-Cramer; Celine B Ord; Gary V Walker; C David Fuller; Jong-Sung Kim; Charles R Thomas
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

2.  Clinical value of Tiam1-Rac1 signaling in primary gallbladder carcinoma.

Authors:  Xilin Du; Shengzhi Wang; Jianguo Lu; Qing Wang; Nuan Song; Tao Yang; Rui Dong; Li Zang; Yuan Yang; Tao Wu; Chengguo Wang
Journal:  Med Oncol       Date:  2011-08-19       Impact factor: 3.064

3.  Breast Cancer Survival Analysis: Applying the Generalized Gamma Distribution under Different Conditions of the Proportional Hazards and Accelerated Failure Time Assumptions.

Authors:  Alireza Abadi; Farzaneh Amanpour; Chris Bajdik; Parvin Yavari
Journal:  Int J Prev Med       Date:  2012-09

Review 4.  A review of approaches to identifying patient phenotype cohorts using electronic health records.

Authors:  Chaitanya Shivade; Preethi Raghavan; Eric Fosler-Lussier; Peter J Embi; Noemie Elhadad; Stephen B Johnson; Albert M Lai
Journal:  J Am Med Inform Assoc       Date:  2013-11-07       Impact factor: 4.497

Review 5.  Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges.

Authors:  Jia-Cheng Tang; Yi-Li Feng; Xiao Liang; Xiu-Jun Cai
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

6.  Parametric survival model to identify the predictors of breast cancer mortality: An accelerated failure time approach.

Authors:  Zeinab Iraji; Tohid Jafari Koshki; Roya Dolatkhah; Mohammad Asghari Jafarabadi
Journal:  J Res Med Sci       Date:  2020-04-13       Impact factor: 1.852

7.  Factors influencing survival time of hemodialysis patients; time to event analysis using parametric models: a cohort study.

Authors:  Vahid Ebrahimi; Mohammad Hossein Khademian; Seyed Jalil Masoumi; Mohammad Reza Morvaridi; Shahrokh Ezzatzadegan Jahromi
Journal:  BMC Nephrol       Date:  2019-06-11       Impact factor: 2.388

8.  Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells.

Authors:  Xiao Liang; JiaCheng Tang; YueLong Liang; RenAn Jin; XiuJun Cai
Journal:  Cell Biosci       Date:  2014-03-03       Impact factor: 7.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.